References
- Busquets S, Ametller E, Fuster G, Olivan M, Raab V, Argilés JM, López-Soriano FJ. 2007. Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model. Cancer Lett. 245(1–2):144–148.
- Csiszar A, Labinskyy N, Olson S, Pinto JT, Gupte S, Wu JM, Hu F, Ballabh P, Podlutsky A, Losonczy G, et al. 2009. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension. 54(3):668–675.
- Danial NN, Korsmeyer SJ. 2004. Cell death: critical control points. Cell. 116(2):205–219.
- Green DR, Kroemer G. 2004. The pathophysiology of mitochondrial cell death. Science. 305(5684):626–629.
- Islam S, Islam N, Kermode T, Johnstone B, Mukhtar H, Moskowitz RW, Goldberg VM, Malemud CJ, Haqqi TM. 2000. Involvement of caspase-3 in epigallocatechin-3-gallatemediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun. 270(3):793–797.
- Kang R, Zeh HJ, Lotze MT, Tang D. 2011. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 18(4):571–580.
- Li-Weber M. 2009. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev. 35(1):57–68.
- Li YH, Wang C, Meng K, Chen LB, Zhou XJ. 2004. Influence of survivin and caspase-3 on cell apoptosis and prognosis in gastric carcinoma. World J Gastroenterol. 10(13):1984–1988.
- Li Z, Zhang Y, Jin T, Men J, Lin Z, Qi P, Piao Y, Yan G. 2015. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers. BMC Cancer. 15:207–209.
- Song M. 2015. Progress in discovery of KIF5B-RET kinase inhibitors for the treatment of non-small-cell lung cancer. J Med Chem. 58(9):3672–3681.
- Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, Mills GB, Kondo S. 2005. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res. 65(8):3336–3346.
- Tanaka T, Nakashima T, Ueda T, Tomii K, Kouno I. 2007. Facile discrimination of aldose enantiomers by reversed-phase HPLC. Chem Pharm Bull. 55(6):899–905.
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. 2015. Global cancer statistics, 2012. CA Cancer J Clin. 65(2):87–108.
- Wang QH, Wu RJ, Qi GQ, Wu JS, Dai NYT, Na RCGT. 2015. Chemical Constituents of Artemisa sacrorum Ledeb. Chin Pharm J. 50:1380–1384.
- Wu LJ, Ban XD, Wang CX. 1994. Study on the chemical constituents of Artemisa sacrorum Ledeb. J Shenyang Pharm Univ. 11:54–57.
- Yu H, Wang QH, Han N, Tu BX, Bu R. 2016. Isolation and identification of six terpenes from the petroleum ether extracts from Artemisa sacrorum Ledeb. Chin J Med Chem. 26:142–145.
- Zhang DZ. 1998. Isolition and identification of two new ent-kauranoid diterpenes from Artemisa sacrorum Ledeb. Nat Prod Res Dev. 10:34–37.
- Zhang DZ, Li X. 1993. Studies on the aromatic constituents from Artemisa sacrorum Ledeb. Chin Trad Herb Drug. 24:283–286.
- Zhang DZ, Li X, Zhu YR. 1990. Study on the chemical constituents of Artemisa sacrorum Ledeb. J Shenyang Pharm Univ. 6:146–149.